Guidance on paediatric submissions

Abbreviations used in EMA scientific committees and CMD documents, and in relation to EMA’s regulatory activities

Eleventh industry stakeholder platform on research and development support, European Medicines Agency, Amsterdam, the Netherlands, 4 December 2023

Human medicines European public assessment report (EPAR): Nulojix, belatacept, Date of authorisation: 17/06/2011, Revision: 21, Status: Authorised

Human medicines European public assessment report (EPAR): Brineura, cerliponase alfa, Date of authorisation: 30/05/2017, Revision: 7, Status: Authorised

Data Analysis and Real World Interrogation Network (DARWIN EU)

DARWIN EU Advisory Board meeting - 24 May 2023, European Medicines Agency, Amsterdam, the Netherlands, from 24 May 2023, 14:30 (CEST) to 24 May 2023, 16:30 (CEST)

Academia Info Day, European Medicines Agency, Amsterdam, the Netherlands, from 10 November 2023, 09:30 (CET) to 10 November 2023, 13:30 (CET)

DARWIN EU Advisory Board meeting: 6 February 2023, Online, European Medicines Agency, Amsterdam, the Netherlands, from 6 February 2023, 10:00 (CET) to 6 February 2023, 12:00 (CET)

Clinical Trials Information System (CTIS): Walk-in clinic - November 2023, Online, European Medicines Agency, Amsterdam, the Netherlands, from 15 November 2023, 16:00 (CET) to 15 November 2023, 17:00 (CET)